Advertisement

Cardiac Tumors: Clinical Presentation, Diagnosis, and Management

  • Timothy J. Poterucha
  • Jonathan Kochav
  • Daniel S. O’Connor
  • Gregg F. RosnerEmail author
Cardio-oncology (MG Fradley, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Cardio-oncology

Opinion statement

Cardiac masses and tumors are a heterogenous group of disorders and include primary tumors (both benign and malignant), metastatic disease, and numerous masquerades such as thrombus. Clinical presentation ranges from incidental discovery on imaging tests ordered for other reasons to life-threatening presentations such as cardiac tamponade, arrhythmia, obstruction, and systemic embolization. Of the available imaging modalities, cardiac MRI is generally the most useful for assessment and helps to delineate the relevant anatomy. Due to the technical difficulties and risk of biopsy of cardiac masses, a presumptive diagnosis is typically made using imaging techniques with surgery serving both a diagnostic and curative role. Because these conditions can vary widely in their management, we recommend early involvement of a multidisciplinary group which should include a cardiologist, cardiac surgeon, and oncologist.

Keywords

Cardiac mass Cardiac tumor Myxoma Rhabdomyoma Rhabdomyosarcoma 

Notes

Compliance with Ethical Standards

Conflict of Interest

Timothy J. Poterucha owns a stock in Abbott Laboratories and AbbVie, Inc.

Jonathan Kochav declares that he has no conflict of interest.

Daniel S. O’Connor declares that he has no conflict of interest.

Gregg F. Rosner declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Al-Mamgani A, Baartman L, Baaijens M, et al. Cardiac metastases. Int J Clin Oncol. 2008;13:369–72.PubMedCrossRefGoogle Scholar
  2. 2.
    Klatt EC, Heitz DR. Cardiac metastases. Cancer. 1990;65:1456–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Primary tumors of the heart. In Bonow RO, Mann DL, Zipes DP, Libby P (eds): Braunwald’s heart disease. 9th ed. Philadelphia, Elsevier Saunders, 2011, pp 1638–1650.Google Scholar
  4. 4.
    Cardiac tumors. In Crawford MH, DiMarco JP and Paulus WJ (eds): Cardiology. 3rd ed. Philadelphia, Elsevier Saunders, 2010, pp 1743–1751.Google Scholar
  5. 5.
    Stollberger C, Chnupa P, Kronik G, Brainin M, Finsterer J, Schneider B, et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in left atrial thrombi. Ann Intern Med. 1998;128:630–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Sharma ND, McCullough PA, Philbin EF, Weaver WD. Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest. 2000;117:314–20.PubMedCrossRefGoogle Scholar
  7. 7.
    Gertner E, Leatherman JW. Intracardiac mural thrombus mimicking atrial myxoma in the antiphospholipid syndrome. J Rheumatol. 1992;19:1293–8.PubMedGoogle Scholar
  8. 8.
    Kirkpatrick JN, Wong T, Bednarz JE, Spencer KT, Sugeng L, Ward RP, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol. 2004;43:1412–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Kassop D, Donovan MS, Cheezum MK, Nguyen BT, Gambill NB, Blankstein R, et al. Cardiac masses on cardiac CT: a review. Curr Cardiovasc Imaging Rep. 2014;7:9281.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    • Giusca S, Mereles D, Ochs A, Buss S, Andre F, Seitz S, et al. Incremental value of cardiac magnetic resonance for the evaluation of cardiac tumors in adults: experience of a high volume tertiary cardiology centre. Int J Card Imaging. 2017;33:879–88 This is a retrospective analysis of a large number of cardiac masses evaluated by cardiac MRI and shows superior mass identification as compared with echocardiography. CrossRefGoogle Scholar
  11. 11.
    Nazarian S, Hansford R, Rahsepar AA, Weltin V, McVeigh D, Gucuk Ipek E, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med. 2017;377:2555–64.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Pazos-Lopez P, Pozo E, Siqueira ME, Garcia-Lunar I, Cham M, Jacobi A, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7:896–905.PubMedCrossRefGoogle Scholar
  13. 13.
    Chan AT, Plodkowski AJ, Pun SC, Lakhman Y, Halpenny DF, Kim J, et al. Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer. J Cardiovasc Magn Reson. 2017;19:76.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Ganame J, Wright J, Bogaert J. Cardiac lipoma diagnosed by cardiac magnetic resonance imaging. Eur Heart J. 2008;29:697.PubMedCrossRefGoogle Scholar
  15. 15.
    Rahbar K, Seifarth H, Schafers M, Stegger L, Hoffmeier A, Spieker T, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53:856–63.PubMedCrossRefGoogle Scholar
  16. 16.
    Chan ATF, J. Perez Johnston, R. Plodkowski, A. Pollie, M. Moskowitz, C. Steingart, R. Weinsaft, J.W. Biologic and prognostic validation of delayed enhancement (DE-) CMR for cancer-associated cardiac masses - multimodality comparison to positron emission tomography (PET) [ABSTRACT]. Society for Cardiovascular Magnetic Resonance Scientific Sessions. 2018:22.Google Scholar
  17. 17.
    Klein MA, Scalcione LR, Youn T, Shah RA, Katz DS, Sung WW, et al. Intensely hypermetabolic lipomatous hypertrophy of the interatrial septum on 18-FDG PET with MRI and CT correlation. Clin Nucl Med. 2010;35:972–3.PubMedCrossRefGoogle Scholar
  18. 18.
    Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Kohler J, et al. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study. J Nucl Med. 2015;56:255–60.PubMedCrossRefGoogle Scholar
  19. 19.
    Theologides A. Neoplastic cardiac tamponade. Semin Oncol. 1978;5:181–92.PubMedGoogle Scholar
  20. 20.
    Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Randomized comparison of low-molecular-weight heparin versus oral anticoagulant therapy for the prevention of recurrent venous thromboembolism in patients with cancer I. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, et al. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018;378:615–24.PubMedCrossRefGoogle Scholar
  22. 22.
    Srichai MB, Junor C, Rodriguez LL, Stillman AE, Grimm RA, Lieber ML, Weaver JA, Smedira NG and White RD. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152:75-84.PubMedCrossRefGoogle Scholar
  23. 23.
    Hong YJ, Hur J, Kim YJ, Lee HJ, Nam JE, Kim HY, Choe KO and Choi BW. The usefulness of delayed contrast-enhanced cardiovascular magnetic resonance imaging in differentiating cardiac tumors from thrombi in stroke patients. Int J Cardiovasc Imaging. 2011;27 Suppl 1:89-95.PubMedCrossRefGoogle Scholar
  24. 24.
    Weinsaft JW, Kim HW, Crowley AL, Klem I, Shenoy C, Van Assche L, Brosnan R, Shah DJ, Velazquez EJ, Parker M, Judd RM and Kim RJ. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging. 2011;4:702-12.PubMedGoogle Scholar
  25. 25.
    Chen-Milhone CS, Chakravarthy Potu K, Mungee S. Cardiac aspergilloma: a rare case of a cardiac mass involving the native tricuspid valve, right atrium, and right ventricle in an immunocompromised patient. Case Rep Cardiol. 2018;2018:6927436.CrossRefGoogle Scholar
  26. 26.
    Biller J, Challa VR, Toole JF, Howard VJ. Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol. 1982;39:95–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Tower-Rader A, Kwon D. Pericardial masses, cysts and diverticula: a comprehensive review using multimodality imaging. Prog Cardiovasc Dis. 2017;59:389–97.PubMedCrossRefGoogle Scholar
  28. 28.
    Yared K, Baggish AL, Picard MH, Hoffmann U, Hung J. Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging. 2010;3:650–60.PubMedGoogle Scholar
  29. 29.
    Frank H, Globits S. Magnetic resonance imaging evaluation of myocardial and pericardial disease. J Magn Reson Imaging. 1999;10:617–26.PubMedCrossRefGoogle Scholar
  30. 30.
    Heyer CM, Kagel T, Lemburg SP, Bauer TT, Nicolas V. Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest. 2003;124:2068–73.PubMedCrossRefGoogle Scholar
  31. 31.
    Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996;77:107.PubMedCrossRefGoogle Scholar
  32. 32.
    Centofanti P, Di Rosa E, Deorsola L, et al. Primary cardiac neoplasms: early and late results of surgical treatment in 91 patients. Ann Thorac Surg. 1999;68:1236–41.Google Scholar
  33. 33.
    Sarjeant JM, Butany J, Cusimano RJ. Cancer of the heart: epidemiology and management of primary neoplasms and metastases. Am J Cardiovasc Drugs. 2003;3:407–21.PubMedCrossRefGoogle Scholar
  34. 34.
    Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma: a series of 112 consecutive cases. Medicine. 2001;80:159–72.PubMedCrossRefGoogle Scholar
  35. 35.
    McAllister H, Fenoglio J. Tumors of the cardiovascular system. In: Hartmannn W, Cowan W, editors. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1978. p. 1–20.Google Scholar
  36. 36.
    Reynen K. Cardiac myxomas. N Engl J Med. 1995;333:1610–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Carney J, Gordon H, Carpenter P, Shenoy B, Go V. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine. 1985;64(4):270–83.PubMedCrossRefGoogle Scholar
  38. 38.
    McCarthy PM, Piehler JM, Schaff HV, Pluth JR, Orszulak TA, Vidaillet HJ Jr, et al. The significance of multiple, recurrent, and “complex” cardiac myxomas. J Thorac Cardiovasc Surg. 1986;91:389–96.Google Scholar
  39. 39.
    Waller DA, Ettles DF, Saunders NR, Williams G. Recurrent cardiac myxoma: the surgical implications of two distinct groups of patients. Thorac Cardiovasc Surg. 1989;37:226–30.PubMedCrossRefGoogle Scholar
  40. 40.
    Mariscalco G, Bruno VD, Borsani P, Dominici C, Sala A. Papillary fibroelastoma: insight to a primary cardiac valve tumor. J Card Surg. 2010;25:198–205.PubMedCrossRefGoogle Scholar
  41. 41.
    Yee HC, Nwosu JE, Lii AD, Velasco M, Millman A. Echocardiographic features of papillary fibroelastoma and their consequences and management. Am J Cardiol. 1997;80:811–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Jain D, Maleszewski JJ, Halushka MK. Benign cardiac tumors and tumorlike conditions. Ann Diagn Pathol. 2010;14:215–30.PubMedCrossRefGoogle Scholar
  43. 43.
    Freedom RM, Lee KJ, MacDonald C, Taylor G. Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol. 2000;21:299–316.PubMedCrossRefGoogle Scholar
  44. 44.
    Uzun O, Wilson DG, Vulanic GM, et al. Cardiac tumours in children. Orphanet J Rare Dis. 2007;2:11.Google Scholar
  45. 45.
    Gunther T, Schreiber C, Noebauer C, Eicken A, Lange R. Treatment strategies for pediatric patients with primary cardiac and pericardial tumors: a 30-year review. Pediatr Cardiol. 2008;29:1071–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Chen TW, Loong HH, Srikanthan A, et al. Primary cardiac sarcomas: a multinational retrospective review. Cancer Med 2018; 1–7.Google Scholar
  47. 47.
    Ramlawi B, Leja MJ, Abu Saleh WK, al Jabbari O, Benjamin R, Ravi V, et al. Surgical treatment of primary cardiac sarcomas: review of a single-institution experience. Ann Thorac Surg. 2016;101:698–702.PubMedCrossRefGoogle Scholar
  48. 48.
    Hamidi M, Moody JS, Weigel TL, Kozak KR. Primary cardiac sarcoma. Ann Thorac Surg. 2010;90:176–81.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, et al. Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group. Eur J Cancer. 2014;50(1):128–36.PubMedCrossRefGoogle Scholar
  50. 50.
    • Randhawa JS, Budd GT, Randhawa M, Ahluwalia M, Jia X, Daw H, et al. Primary cardiac sarcoma: 25-year Cleveland Clinic experience. Am J Clin Oncol. 2016;39(6):593–99. This is a retrospective review of 42 cases of primary cardiac sarcoma and described a benefit in patients who received multimodality therapy.PubMedCrossRefGoogle Scholar
  51. 51.
    Reardon MJ, DeFelice CA, Sheinbaum R, Baldwin J. Cardiac autotransplant for surgical treatment of a malignant neoplasm. Ann Thorac Surg. 1999;67:1793–5.PubMedCrossRefGoogle Scholar
  52. 52.
    •• Abu Saleh WK, Ramlawi B, Shapira OM, et al. Improved outcomes with the evolution of neoadjuvant chemotherapy approach to right heart sarcoma. Ann Thorac Surg. 2017;104(1):90–6. This is a single-center study of 133 primary cardiac sarcoma cases with a focus on the management of right-sided sarcomas. This study demonstrated a marked survival benefit with complete resection, leading to a recommendation for neoadjuvant therapy to increase the probability of achieving complete resection.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Timothy J. Poterucha
    • 1
  • Jonathan Kochav
    • 1
  • Daniel S. O’Connor
    • 1
  • Gregg F. Rosner
    • 1
    Email author
  1. 1.Department of Medicine, Division of CardiologyColumbia University Medical CenterNew YorkUSA

Personalised recommendations